Differential effects of 20-hydroxyeicosatetraenoic acid on intrarenal blood flow in the rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 313, Issue 3, 2005, Pages 1289-1295

  Oyekan, Adebayo O ^a  

^a TEXAS SOUTHERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; 20 HYDROXYPROSTAGLANDIN E2; 20 HYDROXYPROSTAGLANDIN F2 ALPHA; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; INDOMETACIN; N(G) NITRO DEXTRO ARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTANOID; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HEMODYNAMICS; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY MEDULLA; KIDNEY PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION; VASODILATATION;

ANIMALS; CEREBROVASCULAR CIRCULATION; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDRAZINES; HYDROXYEICOSATETRAENOIC ACIDS; INDOMETHACIN; KIDNEY MEDULLA; MALE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; VASOCONSTRICTION;

EID: 19444381235     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.080218     Document Type: Article

References (32)

1. Arima S, Omata K, Ito S, Tsunoda K, and Abe K (1996) 20-HETE requires increased vascular tone to constrict rabbit afferent arterioles. Hypertension 27:781-785.
2. 2 as an endothelium-derived contracting factor modulates endothelin-1-induced contraction. J Hypertens 12:383-390.
3. Birks EK, Bousamra KM, Presberg K, Marsh JA, Effros RM, and Jacobs ER (1997) Human pulmonary arteries dilate to 20-HETE, an endogenous eicosanoid of lung tissue. Am J Physiol Lung Cell Mol Physiol 272:L823-L829.
4. Carroll MA, Balazy M, Huang DD, Rybalova S, Falck RJ, and McGiff JC (1997) Cytochrome P-450-derived renal HETEs: storage and release. Kidney Int 51:1696-1702.
5. Carroll MA, Balazy M, Margiotta P, Huang DD, Falck JR, and McGiff JC (1996) Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides. Am J Physiol Regul Integr Comp Physiol 271:R863-R869.
6. Croft KD, McGiff JC, Sanchez-Mendoza A, and Carroll MA (2000) Angiotensin II releases 20-HETE from rat renal microvessels. Am J Physiol Renal Physiol 279: F544-F551.
7. Deng A and Baylis C (1993) Locally produced EDRF controls preglomerular resistance and ultrafiltration coefficient. Am J Physiol 264:F212-F215.
8. Escalante B, Omata K, Sessa W, Lee SG, Falck JR, and Schwartzman ML (1993) 20-Hydroxyeicosatetraenoic acid is an endothelium-dependent vasoconstrictor in rabbit arteries. Eur J Pharmacol 235:1-7.
9. Escalante B, Sessa WC, Falck JR, Yadagiri P, and Schwartzman ML (1989) Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase. J Pharmacol Exp Ther 248:229-232.
10. Gulbins E, Hoffend J, Zou AP, Dietrich MS, Schlottmann K, Cavarape A, and Steinhausen M (1993) Endothelin and endothelium-derived relaxing factor control of basal renovascular tone in hydronephrotic rat kidneys. J Physiol 469:571-582.
11. Gurbanov K, Rubinstein I, Hoffman A, Abassi Z, Better OS, and Winaver J (1996) Differential regulation of renal regional blood flow by endothelin-1. Am J Physiol 271:F1166-F1172.
12. Hamberg M, Svensson J, Wakabayashi T, and Samuelsson B (1974) Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc Natl Acad Sci USA 71:345-349.
13. Hantz H, Adesuyi A, and Adebayo O (2001) Differential effects of U46619 on renal regional hemodynamics in the rat: involvement of endothelin. J Pharmacol Exp Ther 299:372-376.
14. Harder DR, Gebremedhin D, Narayanan J, Jefcoat C, Falck JR, Campbell WB, and Roman R (1994) Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels. Am J Physiol 266:H2098-H2107.
15. Hercule HC and Oyekan AO (2000) Role of NO and cytochrome P-450-derived eicosanoids in ET-1-induced changes in intrarenal hemodynamics in rats. Am J Physiol 279:R2132-R2141.
16. Hui S-GC and Ogle CW (1993) The hypotensive action of endoperoxide analogs in the rat. Arch Intern Physiol Biochem Biophys 101:43-46.
17. Imig JD (2003) Eicosanoid regulation of the renal vasculature. Am J Physiol Renal Physiol 279:F965-F981.
18. Imig JD, Navar LG, Roman RJ, Reddy KK, and Falck JR (1996) Actions of epoxygenase metabolites on the preglomerular vasculature. J Am Soc Nephrol 7:2364-2370.
19. Jacobs ER, Effros RM, Falck JR, Reddy KM, Campbell WB, and Ahu D (1999) Airway synthesis of 20-hydroxyeicosatetraenoic acid: metabolism by cyclooxygenase to a bronchodilator. Am J Physiol Lung Cell Mol Physiol 276:L280-L288.
20. Malik KU and McGiff JC (1975) Modulation by prostaglandins of adrenergic transmission in the isolated perfused rabbit and rat kidney. Circ Res 36:599-609.
21. Mehta J, Nicolas WW, and Goldman R (1984) Prostaglandin release following endoperoxide analog infusion in the intact dog. Am J Physiol 246:R205-R210.
22. Navar LG, Ichihara A, Chin SY, and Imig JD (2000) Nitric oxide-angiotensin II interactions in angiotensin II-dependent hypertension. Acta Physiol Scand 168:139-147.
23. Nicholson NS, Smith SL, and Fuller GC (1984) Effect of the stable endoperoxide analog U46619 on prostaglandin production and cAMP levels in bovine endothelial cells. Thromb Res 35:183-192.
24. Oyekan AO, Balazy M, and McGiff JC (1997) Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and ANG II. Am J Physiol Regul Integr Comp Physiol 273:R293-R300.
25. Oyekan AO and McGiff JC (1998) Cytochrome P-450-derived eicosanoids participate in the renal functional effects of ET-1 in the anesthetized rat. Am J Physiol Regul Integr Comp Physiol 274:R52-R61.
26. Parekh N, Dobrowolski L, Zou A-P, and Steinhausen M (1996) Nitric oxide modulates angiotensin II- and norepinephrine-dependent vasoconstriction in rat kidney. Am J Physiol 270:R630-R635.
27. Parekh N and Zou A-P (1996) Role of prostaglandins in renal medullary circulation: response to different vasoconstrictors. Am J Physiol 271:F653-F658.
28. Pflueger AC, Larson TS, Hagl S, and Knox FG (1999) Role of nitric oxide in intrarenal hemodynamics in experimental diabetes mellitus in rats. Am J Physiol 277:R725-R733.
29. Pratt PF, Falck JR, Reddy KM, Kurian JB, and Campbell WB (1998) 20-HETE relaxes bovine coronary arteries through the release of prostacyclin. Hypertension 31:237-241.
30. Schwartzman ML, Falck JR, Yadagiri P, and Escalante B (1989) Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase: formation and identification of novel endothelium-dependent vasoconstrictor metabolites. J Biol Chem 264:11658-11662.
31. Zou AP and Cowley AW Jr (1997) Nitric oxide in renal cortex and medulla: an in vivo microdialysis study. Hypertension 29:194-198.
32. Zou AP, Ma YH, Sui ZH, Ortiz de Montellano PR, Clark JE, Masters BS, and Roman RJ (1994) Effects of 17-octadecynoic acid, a suicide-substrate inhibitor of P-450 fatty acid ω-hydroxylase, on renal function of rats. J Pharmacol Exp Ther 268:474-481.